Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.310
-0.040 (-2.96%)
At close: May 13, 2025, 4:00 PM
1.300
-0.010 (-0.76%)
Pre-market: May 14, 2025, 4:25 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Blood Safety
180.27M
Log In
Log In
Log In
Log In
Upgrade
Blood Safety Growth
15.29%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
111.07M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
19.14%
Log In
Log In
Log In
Log In
Upgrade
Europe, Middle East and Africa
36.64M
Log In
Log In
Log In
Log In
Upgrade
Europe, Middle East and Africa Growth
0.32%
Log In
Log In
Log In
Log In
Upgrade
France
19.69M
Log In
Log In
Log In
Log In
Upgrade
France Growth
6.50%
Log In
Log In
Log In
Log In
Upgrade
North America
10.72M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
80.03%
Log In
Log In
Log In
Log In
Upgrade
Other
2.15M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-1.06%
Log In
Log In
Log In
Log In
Upgrade
Belgium
-
Log In
Log In
Log In
Log In
Upgrade
Belgium Growth
-
Log In
Log In
Log In
Log In
Upgrade